How much did NXPharmagen raise?

NXPharmagen raised $486,000 in a Seed round on August 31, 2020.

Nx Pharmagen Inc. reported raising $486,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEAug 31, 2020$486K of $1M raised

Amount Raised

$486,000

$486,000 sold, per SEC Form D (first sale Aug 31, 2020)

Round Type

Seed

LouisvilleBiotechnology

NXPharmagen raised $486,000 in a Seed round, dated August 31, 2020. NXPharmagen is based in Louisville, Kentucky, United States.

How much did NXPharmagen raise?: NXPharmagen raised $486,000 in a Seed round on August 31, 2020.
What does NXPharmagen do?: NX PharmaGen Inc. was founded to invest in technologies that have the potential to enrich the lives of patients.
Where is NXPharmagen based and how big is it?: NXPharmagen is based in Louisville, Kentucky, United States.

Source: Fundz verified event record.

Companies in the same sectors as NXPharmagen that raised within 45 days of this round, from Fundz verified event records.

SRX Global Inc. raised $19M on October 15, 2020.
Alucent Biomedical, Inc. raised $35M on October 15, 2020.
Evofem Biosciences raised $25M (Corporate Round) on October 15, 2020.
Azitra raised an undisclosed amount (Series B) on October 15, 2020.
ORTHO REGENERATIVE TECHNOLOGIES INC. raised $73K (Pre-Seed) on October 15, 2020.
Counterpoint Health Solutions, Inc. raised $3.8M (Seed) on October 15, 2020.

A new round usually means NXPharmagen is about to hire and buy. The teams that reach out first get the meeting.

An alert the day NXPharmagen raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at NXPharmagen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NXPharmagen. With Fundz connected, it knows.

Watch Fundz in

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2